Study guide

9.2 Recognizing Medication Effects & Adverse Reactions

Registered Cardiovascular Invasive Specialist RCIS

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current RCIS Exam Facts 1.2 Eligibility Pathways & Documentation 1.3 Examination Matrix & Study Plan

2 Pre-Procedural Room Setup & Sterile Technique

2.1 Procedure & Control Room Setup 2.2 Sterile Technique & Universal Precautions 2.3 Personnel Preparation & Cath Lab Roles

3 Pre-Procedural Patient Preparation & Validation

3.1 Preparing the Patient for Invasive Procedures 3.2 Records, Labs, Allergies & Consent 3.3 Time-Out & Universal Protocol

4 Patient Monitoring & Vascular Access

4.1 Intraprocedural Vital Sign Monitoring 4.2 Arterial & Venous Access Sites 4.3 Ultrasound-Guided Access

5 Coronary Anatomy & Left Heart Catheterization

5.1 Coronary Anatomy & Dominance 5.2 Left Heart Catheterization & Coronary Angiography 5.3 Catheter Shapes & Angiographic Projections 5.4 Left Ventriculography & Aortography

6 Right Heart Catheterization & Hemodynamics

6.1 Right Heart Waveforms & Pressures 6.2 Cardiac Output: Fick & Thermodilution 6.3 Valve Area, Bernoulli & Shunt Calculations 6.4 Endomyocardial Biopsy Support

7 ECG & Intracardiac/Intravascular Imaging

7.1 12-Lead ECG in the Cath Lab 7.2 Intracardiac Echocardiography (ICE) 7.3 IVUS & OCT 7.4 Identifying Structures on Cardiac Ultrasound

8 Physiology Assessment & Radiation Safety

8.1 FFR & iFR Studies 8.2 Radiation Safety & ALARA 8.3 Radiographic Equipment Operation 8.4 Image Acquisition & Interpretation

9 Cath Lab Pharmacology

9.1 Anticipating Pharmacologic Needs 9.2 Recognizing Medication Effects & Adverse Reactions 9.3 Anticoagulation & ACT Targets

10 PCI Fundamentals

10.1 Balloon Angioplasty & Stent Platforms 10.2 Coronary Wiring, Lesion Prep & Flow Grades 10.3 Vascular Closure Devices

11 Chapter 11: Complex Coronary Intervention

11.1 CTO, Atherectomy & Alcohol Septal Ablation 11.2 Cardiac Thrombectomy (Mechanical & Aspiration) 11.3 Distal Protection Devices

12 Device Implants & Temporary Support

12.1 Pacemaker, ICD, CRT & Loop Recorders 12.2 Transvenous Temporary Pacemaker 12.3 Pericardiocentesis Support

13 Mechanical Circulatory Support

13.1 IABP & Impella 13.2 ECMO & LVAD Overview for the Cath Lab

14 Peripheral Vascular Interventions

14.1 Peripheral Interventions 14.2 Complex Peripheral Interventions 14.3 Peripheral Thrombectomy & Thrombolysis

15 Structural Heart Interventions

15.1 Nonvalvular Structural Therapies 15.2 Percutaneous Valve Interventions

16 Chapter 16: Emergency Clinical Presentations & Equipment

16.1 STEMI, Cardiogenic Shock & Pulmonary Edema 16.2 Stroke & Neurologic Emergencies in the Lab 16.3 Emergency Equipment Operation

17 Intraprocedural Complications

17.1 Coronary Interventional Complications 17.2 Peripheral & Structural Complications

18 Post-Procedural Activities

18.1 Arterial & Venous Hemostasis 18.2 Access-Site Complications 18.3 Patient Education, Reporting & Transfer of Care

9.2 Recognizing Medication Effects & Adverse Reactions

Key Takeaways Explain This Topic AI

Intracoronary nitroglycerin (100–200 mcg) relieves epicardial spasm and aids vessel sizing; IV nitroglycerin lowers preload/BP and is contraindicated with recent PDE5 inhibitors

Adenosine causes transient AV block and hyperemia for FFR; prolonged symptomatic bradycardia requires atropine and possible pacing support

Iodinated contrast reactions range from urticaria to anaphylaxis—severe hypotension with bronchospasm or angioedema requires epinephrine and full resuscitation

Sedation with midazolam/fentanyl can cause respiratory depression; flumazenil and naloxone must be immediately available with continuous SpO₂ monitoring

Vasopressor selection matches the hemodynamic pattern: phenylephrine for vasodilatory hypotension, epinephrine for anaphylaxis and arrest

Last updated: July 2026

9.2 Recognizing Medication Effects & Adverse Reactions

Quick Answer: RCIS Task 13 tests whether you recognize expected therapeutic effects and adverse reactions of cath lab drugs— nitroglycerin , adenosine , atropine , vasopressors , iodinated contrast , sedatives , antiarrhythmics , and anticoagulants —then notify the operator and support stabilization within your scope.

Medication recognition is pattern matching under pressure: a 20 mmHg pressure drop after intracoronary nitroglycerin may be therapeutic ; the same drop after sedation may be dangerous . The RCIS exam rewards candidates who connect drug class → expected effect → warning sign → first action without confusing unrelated complications.

Nitroglycerin (NTG)

Mechanism: Nitric oxide donor → venodilation (preload ↓) and epicardial coronary dilation (spasm relief).

Route Typical cath lab use Expected effects Adverse reactions / pitfalls

Intracoronary (IC) 100–200 mcg for spasm and vessel sizing before PCI Improved luminal diameter; transient BP ↓ Headache; hypotension if hypovolemic; tachyphylaxis with repeated IC doses

IV infusion Hypertensive emergency, flash pulmonary edema (physician-directed) BP ↓, pulmonary congestion ↓ Reflex tachycardia ; hypotension ; contraindicated with PDE5 inhibitors (sildenafil ≤24 h, tadalafil ≤48 h) and suspected RV infarction

RCIS tip: IC nitroglycerin treats epicardial spasm and optimizes angiographic assessment —it is not primarily an antihypertensive for systemic hypertension (that is IV NTG). If BP falls sharply after IC dose in a volume-depleted patient, notify the operator , trend pressures , and prepare IV fluids per orders.

Adenosine

Mechanism: Activates A1 receptors → AV nodal block , coronary hyperemia (FFR), very short half-life (~10 sec) .

Use What you should see Adverse effects Your response

FFR hyperemia (IV or IC) Transient dyspnea , chest heaviness , flushing , brief AV block Prolonged asystole/bradycardia (especially with sick sinus), bronchospasm in reactive airway disease Monitor ECG/pressure continuously ; atropine and temporary pacing available; notify operator if block outlasts drug

SVT termination (IV bolus 6–12 mg) Rapid arrhythmia break Same as above plus hypotension Stop infusion if using pump; record ECG strip

Contraindications/high caution: Second-/third-degree AV block without pacemaker, severe reactive airway disease , hypotension . Methylxanthines (theophylline, caffeine) blunt effect.

Atropine

Mechanism: Anticholinergic → ↑ heart rate, ↑ AV conduction.

Indication Dose Expected effect Toxicity

Symptomatic bradycardia (adenosine, carotid massage, conduction disease) 0.5–1 mg IV , repeat to 3 mg HR ↑, symptoms improve Dry mouth , flushing , urinary retention ; paradoxical bradycardia at low doses possible

Organophosphate/nerve agent (rare) Higher doses per ACLS Secretions ↓ Anticholinergic delirium

In the cath lab, atropine most often follows adenosine-induced AV block or vagal reactions during carotid sinus stimulation or temporary pacing insertion.

Vasopressors and Inotropes

When hypotension threatens coronary perfusion during PCI or after sedation/contrast reaction, operators may order push-dose pressors or infusions.

Agent Primary effect Cath lab context Key adverse effects

Epinephrine α + β agonist Anaphylaxis , cardiac arrest , severe hypotension Tachyarrhythmias , hypertension , demand ischemia

Norepinephrine α > β Sepsis-like or vasodilatory shock after sedation Peripheral ischemia at high doses, arrhythmias

  • Phenylephrine Pure α agonist Hypotension with reflex bradycardia acceptable Hypertension , ↓ HR
  • Dobutamine β1 inotrope Low cardiac output states (caution in ischemia) Tachycardia , ectopy
  • Vasopressin V1 receptor ACLS , vasodilatory shock Ischemic gut/digital ischemia

RCIS action pattern: Notify operator immediately , repeat blood pressure , ensure IV access , prepare ACLS drugs , document time/dose/response . Do not independently titrate infusions outside protocol.

Iodinated Contrast Media

Contrast reactions span mild (nausea, urticaria) to life-threatening anaphylaxis .

  • Reaction severity Findings First-line support (with operator)
  • Mild Rash, pruritus, isolated hives Antihistamine , monitor

Moderate Bronchospasm, diffuse urticaria, facial edema Oxygen , H1/H2 blockers , steroids , albuterol if wheezing

Severe / anaphylaxis Hypotension, angioedema, stridor, shock Epinephrine IM/IV , fluids , airway assessment , call for help

Contrast-induced nephropathy (CIN) is a subacute effect (creatinine rise 48–72 h), not immediate wheezing. Recognize risk factors : CKD, diabetes, heart failure, large contrast volume, hypotension during case.

Extravasation of contrast (not allergy) causes local swelling/pain —elevate limb, monitor pulses, notify operator , document; do not confuse with anaphylaxis.

Sedation: Midazolam, Fentanyl, Propofol

Agent Therapeutic effect Warning signs Reversal / support

Midazolam Anxiolysis, amnesia Respiratory depression , hypotension Flumazenil (caution: seizures if chronic benzo use)

Fentanyl Analgesia Respiratory depression , chest wall rigidity (rare rapid push) Naloxone (may reverse analgesia)

Propofol Deep sedation (where credentialed) Apnea , hypotension Airway support , vasopressors , stop infusion

Monitor SpO₂ , respiratory rate , blood pressure , and level of consciousness per institutional sedation policy. RCIS items may ask what to do when EtCO₂ rises and SpO₂ falls after fentanyl—answer: notify operator , assist ventilation , prepare naloxone .

Antiarrhythmics in the Lab

Drug Use Effect to recognize Toxicity

Amiodarone VT/VF , hemodynamically unstable VT Rate ↓, BP may ↓ (slow infusion) Hypotension (rapid bolus), QT prolongation (chronic)

  • Lidocaine VT (alternative) CNS sedation at high levels Seizures , asystole overdose
  • Procainamide Stable VT (less common now) QRS widens Hypotension , proarrhythmia

During PCI-related VT , your priority is recognition + notification + preparation while the operator directs cardioversion/defibrillation and drug bolus.

Anticoagulation Effects (Intraprocedural)

  • Agent Therapeutic marker Bleeding signal Thrombosis signal
  • UFH ACT in target range Hematoma , groin bleed , ACT too high ACT subtherapeutic , clot in sheath

Bivalirudin ACT (partially) + time from dose Less bleeding than heparin + IIb/IIIa in trials Acute stent thrombosis if stopped early—follow protocol

GP IIb/IIIa Clinical bleeding Thrombocytopenia , mucosal bleeding Used less routinely now

Protamine reverses UFH but can cause hypotension , bradycardia , and anaphylactoid reactions —recognize sudden BP drop after protamine as drug effect , not just vagal.

Pattern Recognition Scenarios for RCIS

Sudden hypotension + flush after IC nitroglycerin in spasm → expected; continue monitoring unless symptomatic or extreme.

Pause >6 sec on ECG after adenosine → usually self-limited; atropine if symptomatic or prolonged.

Wheezing + hypotension after contrast → anaphylaxis pathway , not "mild allergy."

Somnolence + RR 6/min after midazolam/fentanyl → respiratory depression ; airway first.

Groin expanding hematoma with ACT 320 → over-anticoagulation/bleeding ; notify operator, hold further anticoagulation, prepare reversal per orders.

Documentation and Escalation

Every adverse reaction requires:

  • Time of drug and time of symptom onset
  • Vital signs , ECG rhythm , ACT if relevant
  • Interventions given and patient response
  • Operator notification documented

Recognizing medication effects is the safety net behind anticipation—CCI expects you to differentiate therapeutic hypotension from shock , adenosine pause from complete heart block needing pacing , and contrast allergy from extravasation without delaying escalation when the patient is unstable.